Issue Number 2, Winter 1995Contents
The Ombudsman (SWEDISH)
 Requests for copies of this newsletter may be sent to the Managing Editor. NAMA |
Issue Number 2, Winter 1995Contents
The Ombudsman (SWEDISH)
Requests for copies of this newsletter may be sent to the Managing Editor. NAMA |
Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century. For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…
Fifteen Years ago when NAMA first started, methadone advocacy was a few committed individuals who all knew one another. When on those rare occasions that new advocate became active she or he was mentored by a more experienced advocate. A few mistakes were made but the same mistake was seldom made twice. The result of…
Education Series Number 4 April 1994 Herman Joseph, Ph.D. was part of the original team that started methadone treatment at The Rockefeller University. His research and publications have had a major influence on methadone treatment. After leaving the research team at Rockefeller University Dr. Joseph started and administered a methadone clinic for patients on probation…
Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…
Education Series Number 5.2 February 2001 (Revised) Joycelyn Woods has a graduate degree in neuroscience and psychopharmacology. She has published in neuroscience journals and is recognized internationally for her methadone advocacy work. She is a recipient of the “Richard Lane Methadone Advocacy Award.” Basic Opioid Pharmacology All natural and synthetic opioids exhibit a three dimensional…
There are many misperceptions and misunderstanding about the federal regulations and particularly when it comes to issues regarding raising the dose over 100 mgs. Prior to the HIV epidemic in order to raise a patient’s dose it was required for the physician to contact the Food and Drug Administration (FDA) for permission. In the early…